191 related articles for article (PubMed ID: 19388516)
61. Prothrombotic gene variation in patients with large and small vessel disease.
Pruissen DM; Kappelle LJ; Rosendaal FR; Algra A;
Neuroepidemiology; 2008; 31(2):89-92. PubMed ID: 18622144
[TBL] [Abstract][Full Text] [Related]
62. Association between asymmetric dimethylarginine and neopterin in patients with and without angiographic coronary artery disease.
Murr C; Meinitzer A; Grammer T; Schroecksnadel K; Böhm BO; März W; Fuchs D
Scand J Immunol; 2009 Jul; 70(1):63-7. PubMed ID: 19522769
[TBL] [Abstract][Full Text] [Related]
63. Cobalamin, folic acid, and homocysteine.
Varela-Moreiras G; Murphy MM; Scott JM
Nutr Rev; 2009 May; 67 Suppl 1():S69-72. PubMed ID: 19453682
[TBL] [Abstract][Full Text] [Related]
64. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
[TBL] [Abstract][Full Text] [Related]
65. Acute-phase vitamin B12 and folic acid levels in patients with ischemic and hemorrhagic stroke: is there a relationship with prognosis?
Bayir A; Ak A; Ozdinç S; Seydanoğlu A; Köstekçi SK; Kara F
Neurol Res; 2010 Mar; 32(2):115-8. PubMed ID: 19825273
[TBL] [Abstract][Full Text] [Related]
66. Are plasma homocysteine levels related to neurological severity and functional outcome after ischemic stroke in the Korean population?
Song IU; Kim JS; Ryu SY; Lee SB; Lee SJ; Jeong DS; Kim YI; Lee KS
J Neurol Sci; 2009 Mar; 278(1-2):60-3. PubMed ID: 19062047
[TBL] [Abstract][Full Text] [Related]
67. Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis.
Lee SC; Lee KY; Kim YJ; Kim SH; Koh SH; Lee YJ
Eur J Neurol; 2010 Jan; 17(1):45-51. PubMed ID: 19566899
[TBL] [Abstract][Full Text] [Related]
68. [The role of homocysteine thiolactone in some of human diseases].
Sikora M; Twardowski T; Jakubowski H
Postepy Biochem; 2006; 52(4):417-23. PubMed ID: 17536511
[TBL] [Abstract][Full Text] [Related]
69. Serum homocysteine, folic acid and vitamin B12 levels in vitiligo.
Balci DD; Yonden Z; Yenin JZ; Okumus N
Eur J Dermatol; 2009; 19(4):382-3. PubMed ID: 19451048
[No Abstract] [Full Text] [Related]
70. Vitamins and stroke: the homocysteine hypothesis still in doubt.
Ntaios GC; Savopoulos CG; Chatzinikolaou AC; Kaiafa GD; Hatzitolios A
Neurologist; 2008 Jan; 14(1):2-4. PubMed ID: 18195649
[TBL] [Abstract][Full Text] [Related]
71. LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease.
Slowik A; Iskra T; Turaj W; Hartwich J; Dembinska-Kiec A; Szczudlik A
J Neurol Sci; 2003 Oct; 214(1-2):11-6. PubMed ID: 12972382
[TBL] [Abstract][Full Text] [Related]
72. Anti-heparan sulphate antibodies and homocysteine in dementia: markers of vascular pathology?
Briani C; Cagnin A; Gallo L; Toffanin E; Varagnolo M; Zaninotto M; Plebani M; Ricchieri G; Battistin L; Pizzolato G
J Neurol Sci; 2005 Mar; 229-230():215-8. PubMed ID: 15760642
[TBL] [Abstract][Full Text] [Related]
73. Folic acid and vitamin B6 deficiencies related hyperhomocysteinemia in apparently healthy Pakistani adults; is mass micronutrient supplementation indicated in this population?
Iqbal MP; Lindblad BS; Mehboobali N; Yusuf FA; Khan AH; Iqbal SP
J Coll Physicians Surg Pak; 2009 May; 19(5):308-12. PubMed ID: 19409165
[TBL] [Abstract][Full Text] [Related]
74. Improvement in stroke mortality in Canada and the United States, 1990 to 2002.
Yang Q; Botto LD; Erickson JD; Berry RJ; Sambell C; Johansen H; Friedman JM
Circulation; 2006 Mar; 113(10):1335-43. PubMed ID: 16534029
[TBL] [Abstract][Full Text] [Related]
75. Effect of folic acid supplementation on homocysteine level in postmenopausal women.
Sultan N; Khan MA; Malik S
J Ayub Med Coll Abbottabad; 2007; 19(4):78-81. PubMed ID: 18693605
[TBL] [Abstract][Full Text] [Related]
76. Risk factor analysis in ischaemic stroke: a hospital-based study.
Basu AK; Pal SK; Saha S; Bandyopadhyay R; Mukherjee SC; Sarkar P
J Indian Med Assoc; 2005 Nov; 103(11):586, 588. PubMed ID: 16570759
[TBL] [Abstract][Full Text] [Related]
77. Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease.
Mager A; Orvin K; Koren-Morag N; Lev IE; Assali A; Kornowski R; Shohat M; Battler A; Hasdai D
Am J Cardiol; 2009 Sep; 104(6):745-9. PubMed ID: 19733705
[TBL] [Abstract][Full Text] [Related]
78. Early markers of occult megaloblastosis for low-cost detection of hyperhomocysteinemia in patients with ischaemic stroke: preventive approach for primary health care.
Neogi SS; Thomas M; Sharma A; Kumar J; Khanduri U
Can J Physiol Pharmacol; 2014 Sep; 92(9):713-6. PubMed ID: 25068715
[TBL] [Abstract][Full Text] [Related]
79. Serum homocysteine: relationship with circulating levels of cortisol and ascorbate.
Cascalheira JF; Parreira MC; Viegas AN; Faria MC; Domingues FC
Ann Nutr Metab; 2008; 53(1):67-74. PubMed ID: 18827476
[TBL] [Abstract][Full Text] [Related]
80. Homocysteine and its relationship to stroke subtypes in a UK black population: the south London ethnicity and stroke study.
Khan U; Crossley C; Kalra L; Rudd A; Wolfe CD; Collinson P; Markus HS
Stroke; 2008 Nov; 39(11):2943-9. PubMed ID: 18757289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
